Universe Pharmaceuticals (UPC) Competitors $3.42 0.00 (0.00%) Closing price 03:57 PM EasternExtended Trading$3.40 -0.02 (-0.73%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock UPC vs. EVOK, KPRX, CELZ, NLSP, MBIO, CYCN, APM, AEON, ALZN, and GNPXShould you be buying Universe Pharmaceuticals stock or one of its competitors? The main competitors of Universe Pharmaceuticals include Evoke Pharma (EVOK), Kiora Pharmaceuticals (KPRX), Creative Medical Technology (CELZ), NLS Pharmaceutics (NLSP), Mustang Bio (MBIO), Cyclerion Therapeutics (CYCN), Aptorum Group (APM), AEON Biopharma (AEON), Alzamend Neuro (ALZN), and GENPREX (GNPX). These companies are all part of the "pharmaceutical products" industry. Universe Pharmaceuticals vs. Its Competitors Evoke Pharma Kiora Pharmaceuticals Creative Medical Technology NLS Pharmaceutics Mustang Bio Cyclerion Therapeutics Aptorum Group AEON Biopharma Alzamend Neuro GENPREX Evoke Pharma (NASDAQ:EVOK) and Universe Pharmaceuticals (NYSE:UPC) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation. Do insiders and institutionals hold more shares of EVOK or UPC? 0.2% of Universe Pharmaceuticals shares are held by institutional investors. 2.3% of Evoke Pharma shares are held by company insiders. Comparatively, 57.4% of Universe Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor EVOK or UPC? In the previous week, Evoke Pharma had 9 more articles in the media than Universe Pharmaceuticals. MarketBeat recorded 9 mentions for Evoke Pharma and 0 mentions for Universe Pharmaceuticals. Universe Pharmaceuticals' average media sentiment score of 0.00 beat Evoke Pharma's score of -0.06 indicating that Universe Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Evoke Pharma Neutral Universe Pharmaceuticals Neutral Is EVOK or UPC more profitable? Universe Pharmaceuticals has a net margin of 0.00% compared to Evoke Pharma's net margin of -42.07%. Universe Pharmaceuticals' return on equity of 0.00% beat Evoke Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Evoke Pharma-42.07% -93.51% -33.60% Universe Pharmaceuticals N/A N/A N/A Which has stronger valuation & earnings, EVOK or UPC? Evoke Pharma has higher earnings, but lower revenue than Universe Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEvoke Pharma$12.79M0.72-$5.35M-$2.56-2.39Universe Pharmaceuticals$19.29M0.10-$6.16MN/AN/A Which has more volatility & risk, EVOK or UPC? Evoke Pharma has a beta of -0.04, meaning that its share price is 104% less volatile than the S&P 500. Comparatively, Universe Pharmaceuticals has a beta of 1.43, meaning that its share price is 43% more volatile than the S&P 500. SummaryUniverse Pharmaceuticals beats Evoke Pharma on 8 of the 11 factors compared between the two stocks. Get Universe Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for UPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPC vs. The Competition Export to ExcelMetricUniverse PharmaceuticalsPharmaceutical IndustryMedical SectorNYSE ExchangeMarket Cap$1.93M$806.51M$5.76B$20.88BDividend YieldN/A4.84%3.91%3.59%P/E RatioN/A1.1530.7828.34Price / Sales0.1025.87457.7654.38Price / CashN/A19.5625.2217.82Price / Book0.026.609.364.54Net Income-$6.16M-$4.93M$3.26B$992.74M7 Day Performance-3.53%-0.17%1.83%0.29%1 Month Performance4.59%-0.30%3.69%1.13%1 Year Performance-99.85%20.91%28.88%11.00% Universe Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPCUniverse PharmaceuticalsN/A$3.42flatN/A-99.8%$1.93M$19.29M0.00220Gap UpEVOKEvoke Pharma0.5362 of 5 stars$5.12-6.4%N/A+3.7%$7.64M$10.25M-1.794Earnings ReportGap DownKPRXKiora Pharmaceuticals3.2292 of 5 stars$2.51+2.2%$10.00+299.2%-23.4%$7.62M$16.02M-0.8610Short Interest ↓Gap UpCELZCreative Medical Technology2.0014 of 5 stars$2.94+0.5%N/A-6.0%$7.60M$10K-0.925Short Interest ↓NLSPNLS PharmaceuticsN/A$2.08+0.1%N/A+1,344.6%$7.49MN/A0.006Short Interest ↓MBIOMustang Bio1.0597 of 5 stars$1.71-3.1%N/A-90.8%$7.47MN/A-0.02100Positive NewsShort Interest ↓Gap DownCYCNCyclerion Therapeutics2.716 of 5 stars$2.22+2.5%N/A+1.2%$7.43M$2M-3.0130Positive NewsShort Interest ↓APMAptorum Group0.6902 of 5 stars$1.38-2.8%N/A-57.5%$7.38M$430K0.0030Gap DownAEONAEON Biopharma3.4244 of 5 stars$0.63-3.7%$360.00+56,862.0%-99.0%$7.15MN/A3.515Gap DownALZNAlzamend Neuro2.5597 of 5 stars$2.44+1.7%$180.00+7,277.0%-87.0%$7.08MN/A0.004Short Interest ↑GNPXGENPREX1.7012 of 5 stars$0.21-0.8%N/A-70.5%$7.03MN/A0.0020News CoverageEarnings ReportShort Interest ↑Gap Up Related Companies and Tools Related Companies EVOK Alternatives KPRX Alternatives CELZ Alternatives NLSP Alternatives MBIO Alternatives CYCN Alternatives APM Alternatives AEON Alternatives ALZN Alternatives GNPX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPC) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Universe Pharmaceuticals INC Please log in to your account or sign up in order to add this asset to your watchlist. Share Universe Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access